Why Is Coherus BioSciences Stock Trading Higher Today?

Coherus BioSciences Inc CHRS shares are trading higher after the company agreed to divest its Cimerli ophthalmology franchise to Sandoz Group AG SDZNY SDZXF for $170 million plus an additional amount for inventory. This divestiture aligns with Coherus’ strategic focus on oncology, and includes…#chrs #cimerli #sandozgroupag #sdzxf #dennylanfear #udenyca #fda #udenycaonbody
Source: Reuters: Health - Category: Consumer Health News Source Type: news